The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
10-year follow-up after interferon-α therapy for chronic hepatitis C
Open accessAbstract
Sustained responses to interferon-α occur in 10% to 25% of patients with chronic hepatitis C, but the long-term outcome is not well defined. We evaluated the long-term clinical, histological, and virological outcomes of 10 patients with chronic hepatitis C who were treated between 1984 and 1987 with interferon-α-2b for 52 ± 6 weeks (total doses of 492 ± 116 MU). Before therapy, all 10 had hepatitis C virus (HCV) RNA, elevations of serum aminotransferases, and chronic hepatitis with fibrosis on liver biopsy. Clinical follow up was 6 to 13 years, and liver biopsies were done 5 to 11 years after initiation of therapy. HCV RNA was assayed by qualitative and quantitative reverse transcriptase-polymerase chain reaction assays. Among 5 patients who had a 6-month sustained response after therapy, all remained HCV RNA negative, and at last follow-up, 4 had normal and 1 minimally elevated serum aminotransferase levels. Liver biopsy specimens were nonreactive for HCV RNA, and all the patients showed improvements in both inflammation and fibrosis and were either normal or had mild, nonspecific inflammatory changes. Among 5 patients without a sustained response, all continued to have HCV RNA in serum and persistent or intermittent aminotransferase elevations. Liver biopsy specimens showed little or no change in necrosis and inflammation; all except 1 patient had progression of fibrosis scores or cirrhosis. All 5 patients had symptoms of chronic hepatitis, 1 underwent liver transplantation, and another had progressive hepatic decompensation. In conclusion, patients with a 6-month posttreatment virological response have a favorable long-term clinical and histological outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Self-citationTreatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212203 · Cited by 1,633
Recombinant Interferon Alfa Therapy for Chronic Hepatitis C
Di Bisceglie, A. M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S. M., & Hoofnagle, J. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212204 · Cited by 1,212
Self-citationClinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
Hoofnagle, J. H., Mullen, K. D., Jones, D. B., Rustgi, V., Di Bisceglie, A., Peters, M., Waggoner, J. G., Park, Y., & Jones, E. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152503 · Cited by 972
Self-citationHepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Detection of hepatitis C viral sequences in non-A, non-B hepatitis
WEINER, A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90134-q · Cited by 725
Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B
Feinstone, S. M., Kapikian, A. Z., Purcell, R. H., Alter, H. J., & Holland, P. V. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921502 · Cited by 690
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., & Maertens, G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 685
Poynard, T., Leroy, V, Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., & Zarski, J. P. (1996) · Hepatology · doi:10.1002/hep.510240405 · Cited by 671
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00003 · Cited by 559
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Viral Hepatitis and Liver Disease
Gupta, S., & Ott, M. (1998) · Principles of Molecular Medicine · doi:10.1007/978-1-59259-726-0_43 · Cited by 518
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Ribavirin as Therapy for Chronic Hepatitis C: A Randomized, Double-Blind, Placebo-Controlled Trial
Di Bisceglie, A. M., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D. E., Mahaney, K., & Hoofnagle, J. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00001 · Cited by 328
Self-citationSimmonds, P., Rose, K. A., Graham, S., Chan, S. W., McOmish, F., Dow, B. C., Follett, E. A., Yap, P. L., & Marsden, H. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.6.1493-1503.1993 · Cited by 248
Long–Term Follow–Up of Patients With Chronic Hepatitis C Treated With α–Interferon
Shindo, M., di Bisceglie, A. M., & Hoofnagle, J. H. (1992) · Hepatology · doi:10.1002/hep.1840150607 · Cited by 180
Self-citationTong, M. J., Reddy, K. R., Lee, W. M., Pockros, P. J., Hoefs, J. C., Keeffe, E. B., Hollinger, F. B., Hathcote, E. J., White, H., Foust, R. T., et al. (1997) · Hepatology · doi:10.1002/hep.510260330 · Cited by 179
Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B
Fong, T.-L., Di Bisceglie, A. M., Gerber, M. A., Waggoner, J. G., & Hoofnagle, J. H. (1993) · Hepatology · doi:10.1002/hep.1840180605 · Cited by 176
Self-citationSaracco, G. M., Rosina, F., Abate, M. L., Chiandussi, L., Gallo, V., Cerutti, E., Napoli, A. D., Solinas, A., Deplano, A., Tocco, A., et al. (1993) · Hepatology · doi:10.1002/hep.1840180603 · Cited by 168
Long-term course of interferon-treated chronic hepatitis C
Cammà, C., Marco, V. D., Iacono, O. L., Almasio, P. L., Giunta, M., Fuschi, P., Vaccaro, A., Fabiano, C., Magrin, S., Stefano, R. D., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80274-2 · Cited by 81
Therapy of hepatitis C: Interferon alfa-n1 trials
Farrell, G. C. (1997) · Hepatology · doi:10.1002/hep.510260717 · Cited by 47
Cited by
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
Self-citationMcHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Dienstag, J. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801644 · Cited by 961
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Self-citation
Metadata
- Authors
- Lau, D. T., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H.
- Venue
- Hepatology
- Published
- 1998-10
- Volume
- 28
- Issue
- 4
- Pages
- 1121-1127
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2005863439
- Cited by
- 266
- References
- 25
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.